High Tower Advisors, LLC Immunome Inc. Transaction History

High Tower Advisors, LLC

  • $68.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
SELL
$7.3 - $10.73 $14,600 - $21,460
-2,000 Reduced 10.63%
16,818 $179,000
Q3 2023

Nov 08, 2023
BUY
$6.17 - $9.16 $18,510 - $27,480
3,000 Added 18.97%
18,818 $157,000
Q2 2023

Aug 14, 2023
SELL
$4.7 - $7.91 $4,700 - $7,910
-1,000 Reduced 5.95%
15,818 $125,000
Q1 2023

May 11, 2023
BUY
$3.26 - $5.69 $54,826 - $95,694
16,818 New
16,818 $83,000

Others Institutions Holding IMNM

# of Institutions
122
Shares Held
47.1M
Call Options Held
322K
Put Options Held
1.91M
View Full List

About Immunome Inc.

IMNM Quotes by TradingView
  • Ticker IMNM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,127,400
  • Market Cap $110M
  • Description
  • Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...
More about IMNM
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email